1st Quarter - Amendment

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 10, 2014 — Replaced
1st Quarter - Amendment (this page) Jul 30, 2019 — Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patients' Access to Treatment (HR 460) FDA Safety Over Sequestration At (HR 2725/S 1413) Preserving Access to Orphan Drugs Act (S 1128/HR 2315) Medical Foods for Inborn Errors of Metabolism

LobbyistCovered position, as disclosed
DIANE EDQUIST DORMAN —
PAUL MELMEYER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Social Security Administration (SSA); SENATE

Bills named: H.R. 2725 (113th), H.R. 460 (113th), H.R. 2315 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.